Uploaded December 2025 | Updated September 2026, 3 days ago
For the fourth episode of our highlights from the EASD Annual Meeting 2025 in Vienna series, we invited Dr. Vaios Koutroukas, a clinical researcher at the University of Leicester in the UK.
In his personal highlight from the EASD Annual Meeting 2025, Dr. Koutroukas explores factors promoting progression from level 1 to level 2 hypoglycaemia in the HYPO-METRICS study.
The Hypo-METRICS study investigate the rates and duration of sensor-detected hypoglycaemia (SDH) and their relationship with person-reported hypoglycaemia in people living with type 1 diabetes and insulin-treated type 2 diabetes with prior episodes of hypoglycaemia in the last 3 months.
#Diabetes #EASD2025 #hypoglycemia #type2diabetes #type1diabetes #glucosemonitoring
For the fourth episode of our highlights from the EASD Annual Meeting 2025 in Vienna series, we invited Dr. Vaios Koutroukas, a clinical researcher at the University of Leicester in the UK.
In his personal highlight from the EASD Annual Meeting 2025, Dr. Koutroukas explores factors promoting progression from level 1 to level 2 hypoglycaemia in the HYPO-METRICS study.
The Hypo-METRICS study investigate the rates and duration of sensor-detected hypoglycaemia (SDH) and their relationship with person-reported hypoglycaemia in people living with type 1 diabetes and insulin-treated type 2 diabetes with prior episodes of hypoglycaemia in the last 3 months.
#Diabetes #EASD2025 #hypoglycemia #type2diabetes #type1diabetes #glucosemonitoring










